Biomarkers for detection of alcohol consumption in liver transplantation.

Alcoholic liver disease is an established, yet controversial, indication for liver transplantation. Although an abstinence period of up to 6 mo prior to transplantation is mandatory, alcohol relapse after transplantation is a common event. In case of recurrence of heavy drinking, graft survival is significantly impaired. Guidelines on detection and surveillance of alcohol consumption in this patient cohort are lacking. This review summarizes the challenge of patient selection as well as the current knowledge on established and novel alcohol biomarkers with special focus on liver transplant candidates and recipients.

• Publication year

  2016

• Venue

  World Journal of Gastroenterology

• Publication date

  2016-04-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.3748/wjg.v22.i14.3725PMID 27076757PMCID PMC4814735
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 2014 consensus for the use of alcohol markers in hair for assessment of both abstinence and chronic excessive alcohol consumption.

  2015cited by this paper
• Determination of Ethyl Glucuronide in Hair for Detection of Alcohol Consumption in Patients After Liver Transplantation

  2015cited by this paper
• Phosphatidylethanol Compared with Other Blood Tests as a Biomarker of Moderate Alcohol Consumption in Healthy Volunteers: A Prospective Randomized Study.

  2015cited by this paper
• Influence of repeated permanent coloring and bleaching on ethyl glucuronide concentrations in hair from alcohol-dependent patients.

  2015cited by this paper
• The Utility of Commonly Used Laboratory Tests to Screen for Excessive Alcohol Use in Clinical Practice.

  2015cited by this paper
• Quantification of phosphatidylethanol 16:0/18:1, 18:1/18:1, and 16:0/16:0 in venous blood and venous and capillary dried blood spots from patients in alcohol withdrawal and control volunteers

  2015cited by this paper
• Novel serum biomarkers for detection of excessive alcohol use.

  2015cited by this paper
• Diagnostic sensitivity of carbohydrate deficient transferrin in heavy drinkers

  2014cited by this paper
• Risk factors for alcohol relapse after liver transplantation for alcoholic cirrhosis in Japan

  2014cited by this paper
• Hair ethyl glucuronide levels as a marker for alcohol use and abuse: a review of the current state of the art.

  2014cited by this paper
• Ethyl glucuronide and ethyl sulfate assays in clinical trials, interpretation, and limitations: results of a dose ranging alcohol challenge study and 2 clinical trials.

  2014cited by this paper
• Influence of thermal hair straightening on ethyl glucuronide content in hair.

  2014cited by this paper
• Ethyl glucuronide (EtG): better than breathalyser or self-reports to detect covert short-term relapses into drinking.

  2014cited by this paper
• Assessment of alcohol consumption in liver transplant candidates and recipients: The best combination of the tools available

  2014cited by this paper
• Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease.

  2014cited by this paper
• Determination of ethyl glucuronide in hair improves evaluation of long‐term alcohol abstention in liver transplant candidates

  2014cited by this paper
• Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease.

  2014cited by this paper
• Non-oxidative ethanol metabolites as a measure of alcohol intake.

  2013cited by this paper
• Involvement of UDP-Glucuronosyltransferases UGT1A9 and UGT2B7 in Ethanol Glucuronidation, and Interactions with Common Drugs of Abuse

  2013cited by this paper
• Student drinking patterns and blood alcohol concentration on commercially organised pub crawls in the UK.

  2013cited by this paper
• Liver transplant patients

  2013cited by this paper
• An evaluation of the DRI-ETG EIA method for the determination of ethyl glucuronide concentrations in clinical and post-mortem urine.

  2013cited by this paper
• Higher levels of hair ethyl glucuronide in patients with decreased kidney function.

  2013cited by this paper
• Ethyl glucuronide identified in commercial hair tonics.

  2013cited by this paper
• Variability in the Blood/Breath Alcohol Ratio and Implications for Evidentiary Purposes

  2013cited by this paper
• Determination of ethyl glucuronide levels in hair for the assessment of alcohol abstinence.

  2013cited by this paper
• Impulsivity in adult ADHD patients with and without cocaine dependence.

  2013cited by this paper
• The biometric measurement of alcohol consumption.

  2012cited by this paper
• Alcoholic liver disease.

  2012cited by this paper
• EASL clinical practical guidelines: management of alcoholic liver disease.

  2012cited by this paper
• Monitoring of the alcohol biomarkers PEth, CDT and EtG/EtS in an outpatient treatment setting.

  2012cited by this paper
• The influence of ethanol containing cosmetics on ethyl glucuronide concentration in hair.

  2012cited by this paper
• Practical experiences in application of hair fatty acid ethyl esters and ethyl glucuronide for detection of chronic alcohol abuse in forensic cases.

  2012cited by this paper
• Inhibition of bacterial degradation of EtG by collection as dried urine spots (DUS)

  2012cited by this paper
• Formation of phosphatidylethanol and its subsequent elimination during an extensive drinking experiment over 5 days.

  2012cited by this paper
• Detection of alcohol consumption in patients with alcoholic liver cirrhosis during the evaluation process for liver transplantation

  2012cited by this paper
• Alcohol and substance use in liver transplant patients.

  2011cited by this paper
• Changes in transferrin glycosylation during pregnancy may lead to false-positive carbohydrate-deficient transferrin (CDT) results in testing for riskful alcohol consumption.

  2011cited by this paper
• LC-MS/MS analysis of phosphatidylethanol in dried blood spots versus conventional blood specimens

  2011cited by this paper
• Substance use by liver transplant candidates: An anonymous urinalysis study

  2011cited by this paper
• Urinary ethyl glucuronide as a novel screening tool in patients pre‐ and post–liver transplantation improves detection of alcohol consumption

  2011cited by this paper
• Liver Transplantation for Alcoholic Liver Disease in Europe: A Study from the ELTR (European Liver Transplant Registry)

  2010cited by this paper
• Urine tested positive for ethyl glucuronide and ethyl sulphate after the consumption of "non-alcoholic" beer.

  2010cited by this paper
• CLINICAL STUDY/BIOMARKER: Phosphatidylethanol: normalization during detoxification, gender aspects and correlation with other biomarkers and self‐reports

  2010cited by this paper
• Urine tested positive for ethyl glucuronide and ethyl sulfate after the consumption of yeast and sugar.

  2010cited by this paper
• Alcohol use while on the liver transplant waiting list: A single‐center experience

  2010cited by this paper
• Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis.

  2010cited by this paper
• Preliminary evaluation of phosphatidylethanol and alcohol consumption in patients with liver disease and hypertension.

  2009cited by this paper
• Erythrocyte mean cell volume--correlation to drinking pattern in heavy alcoholics.

  2009cited by this paper
• Comparison of ethyl glucuronide in hair with carbohydrate-deficient transferrin in serum as markers of chronic high levels of alcohol consumption.

  2009cited by this paper
• Phosphatidylethanol: Normalisation during detoxification, gender aspects and correlation with other biomarkers and self-reports

  2009cited by this paper
• Effect of alcoholic liver disease and hepatitis C infection on waiting list and posttransplant mortality and transplant survival benefit

  2009cited by this paper
• Meta‐analysis of risk for relapse to substance use after transplantation of the liver or other solid organs

  2008cited by this paper
• BIOMARKER: Phosphatidylethanol as a sensitive and specific biomarker—comparison with gamma‐glutamyl transpeptidase, mean corpuscular volume and carbohydrate‐deficient transferrin

  2007cited by this paper
• Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. Analyte definition and proposal of a candidate reference method

  2007cited by this paper
• Toward standardization of carbohydrate-deficient transferrin ( CDT ) measurements : I . Analyte definition and proposal of a candidate reference method 1 )

  2007cited by this paper
• Urinary ethyl glucuronide testing detects alcohol consumption in alcoholic liver disease patients awaiting liver transplantation

  2007cited by this paper
• Postcollection synthesis of ethyl glucuronide by bacteria in urine may cause false identification of alcohol consumption.

  2007cited by this paper
• Liver transplantation alcohol related liver disease: (deliberately) stirring a hornet’s nest!

  2006cited by this paper
• PHosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients.

  2006cited by this paper
• Helping Patients Who Drink Too Much

  2005cited by this paper
• Nonalcoholic steatohepatitis

  2005cited by this paper
• [Biological markers of alcoholism].

  2005cited by this paper
• Urinary tract infection: a risk factor for false-negative urinary ethyl glucuronide but not ethyl sulfate in the detection of recent alcohol consumption.

  2005cited by this paper
• Alcohol recidivism impairs long‐term patient survival after orthotopic liver transplantation for alcoholic liver disease

  2005cited by this paper
• Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.

  2005cited by this paper
• Detection of recent ethanol intake with new markers: comparison of fatty acid ethyl esters in serum and of ethyl glucuronide and the ratio of 5-hydroxytryptophol to 5-hydroxyindole acetic acid in urine.

  2005cited by this paper
• Mass spectrometric identification of ethyl sulfate as an ethanol metabolite in humans.

  2004cited by this paper
• Alcohol and cirrhosis: dose--response or threshold effect?

  2004cited by this paper
• On sensitivity, specificity, and the influence of various parameters on ethyl glucuronide levels in urine--results from the WHO/ISBRA study.

  2004cited by this paper
• Recurrence of alcohol ingestion in liver transplantation candidates.

  2003cited by this paper
• Biological markers in alcoholism.

  2003cited by this paper
• Diagnostic characteristics of different carbohydrate-deficient transferrin methods in the detection of problem drinking: effects of liver disease and alcohol consumption.

  2003cited by this paper
• Effect of hair care and hair cosmetics on the concentrations of fatty acid ethyl esters in hair as markers of chronically elevated alcohol consumption.

  2003cited by this paper
• Timing of liver transplantation in alcoholic cirrhosis.

  2003cited by this paper
• Comparison of urinary excretion characteristics of ethanol and ethyl glucuronide.

  2002cited by this paper
• Carbohydrate-deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study.

  2002cited by this paper
• Relationships between effects of smoking, gender, and alcohol dependence on platelet monoamine oxidase-B: activity, affinity labeling, and protein measurements.

  2002cited by this paper
• Laboratory tests for acute alcohol consumption: results of the WHO/ISBRA Study on State and Trait Markers of Alcohol Use and Dependence.

  2002cited by this paper
• Direct Quantification of Ethyl Glucuronide in Clinical Urine Samples by Liquid Chromatography–Mass Spectrometry

  2002cited by this paper
• Biochemical and anatomical evidence for specialized voltage-dependent calcium channel gamma isoform expression in the epileptic and ataxic mouse, stargazer.

  2001cited by this paper
• Carbohydrate-Deficient Transferrin and Chronic Alcohol Ingestion in Subjects with Transferrin CD-Variants

  2001cited by this paper
• Carbohydrate deficient transferrin in abstaining patients with end-stage liver disease.

  2001cited by this paper
• Orthotopic liver transplantation for alcoholic liver disease: A retrospective analysis of survival, recidivism, and risk factors predisposing to recidivism

  2001cited by this paper
• Long-term medical and psycho-social evaluation of patients undergoing orthotopic liver transplantation for alcoholic liver disease

  2000cited by this paper
• Long‐term medical and psycho‐social evaluation of patients undergoing orthotopic liver transplantation for alcoholic liver disease

  2000cited by this paper
• Comparison of urinary 5-hydroxytryptophol, breath ethanol, and self-report for detection of recent alcohol use during outpatient treatment: a study on methadone patients.

  1999cited by this paper
• Influence of age, alcohol consumption and abstinence on the sensitivity of carbohydrate-deficient transferrin, gamma-glutamyltransferase and mean corpuscular volume.

  1999cited by this paper
• Ethyl glucuronide--a marker of alcohol consumption and a relapse marker with clinical and forensic implications.

  1999cited by this paper
• Carbohydrate-deficient transferrin as compared to other markers of alcoholism: a systematic review.

  1999cited by this paper
• Phosphatidylethanol in blood as a marker of ethanol consumption in healthy volunteers: comparison with other markers.

  1998cited by this paper
• Meta-analysis of alcohol intake in relation to risk of liver cirrhosis.

  1998cited by this paper
• Carbohydrate-deficient transferrin: diagnostic efficiency among patients with end-stage liver disease before and after liver transplantation.

  1998cited by this paper
• The kinetics of methanol elimination in alcoholics and the influence of ethanol.

  1997cited by this paper
• Drinking habits as cofactors of risk for alcohol induced liver damage

  1997cited by this paper
• Excess weight risk factor for alcoholic liver disease

  1997cited by this paper
• Blood phosphatidylethanol as a marker of alcohol abuse: levels in alcoholic males during withdrawal.

  1997cited by this paper
• Prediction of risk of liver disease by alcohol intake, sex, and age: A prospective population study

  1996cited by this paper
• Longitudinal comparison of carbohydrate-deficient transferrin and gamma-glutamyl transferase: complementary markers of excessive alcohol consumption.

  1996cited by this paper
• Carbohydrate-deficient transferrin as a marker of alcohol intake: a study with healthy subjects.

  1996cited by this paper

• Radiological Insights into Alcohol Use Associated Disorders and Diseases: Part I

  2026cites this paper
• Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with alcohol use disorder and liver disease at a liver transplant center

  2025cites this paper
• Post Liver Transplant Management and Outcomes in Alcohol-Related Liver Disease.

  2025cites this paper
• Laboratory requirements for assessment of alcohol misuse

  2025cites this paper
• Early liver transplantation in Alcohol-Associated liver disease - evolution of practice, patient selection, management & outcomes.

  2025cites this paper
• Alcohol Use among Young Women in Kampala City: Comparing Self-Reported Survey Data with Presence of Urinary Ethyl Glucuronide Metabolite

  2024cites this paper
• Influence of Alcohol on Intracerebral Hemorrhage: From Oxidative Stress to Glial Cell Activation

  2024cites this paper
• [Problems of ethyl glucuronide use in ethanol consumption diagnosis].

  2024cites this paper
• Use of Phosphatidylethanol Testing in Patients With Liver Disease

  2023influential citation
• Biomarkers for monitoring alcohol sobriety after liver transplantation for alcoholic liver disease

  2023cites this paper
• Universal alcohol biomarker monitoring improves drinking detection and accountability during evaluation for liver transplantation

  2023cites this paper
• Narrowing the Patient–Physician Gap Based on Self-Reporting and Monthly Hepatologist Feedback for Patients With Alcohol-Related Liver Disease: Interventional Pilot Study Using a Journaling Smartphone App

  2022cites this paper
• Alcohol use disorders, self-help groups as a supplement to pharmacological and psychological therapy? A retrospective study in a population with alcohol related liver disease.

  2022cites this paper
• Clinical and diagnostic value of alcohol biomarkers

  2022cites this paper
• Periodontal pathology in patients with cirrhosis of the liver

  2022cites this paper
• Blood phosphatidylethanol (PEth) positivity associates with unfavorable waitlist-related outcomes for patients medically appropriate for liver transplant.

  2022cites this paper
• Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease.

  2022cites this paper
• Detection of unreported alcohol consumption in fatty liver disease.

  2022cites this paper
• Clinical Applications of State Alcohol Biomarkers: An update

  2022cites this paper
• Psychosocial evaluation for liver transplantation: A brief guide for gastroenterologists.

  2021cites this paper
• Psychosocial evaluation for liver transplantation: A brief guide for gastroenterologists

  2021influential citation
• [New biochemical markers of ethyl alcohol abuse - new possibilities in clinical practice].

  2021cites this paper
• Biomonitoring of fast-elimination endocrine disruptors - Results from a 6-month follow up on human volunteers with repeated urine and hair collection.

  2021cites this paper
• An Essential Guide for Managing Post-Liver Transplant Patients: What Primary Care Physicians Should Know.

  2021cites this paper
• Direct Alcohol Biomarkers Prediction Capacity on Relapse and Mortality in Liver Transplantation Candidates: A Follow-Up Study

  2021cites this paper
• Features of therapy of alcoholic liver disease in persons of young age

  2020cites this paper
• Adult Alcoholic Liver Disease

  2020cites this paper
• Alcohol: the role in nutrition and health

  2020cites this paper
• Impact of PNPLA3 (rs738409‐G) polymorphism on post‐transplant outcomes after liver transplantation for alcohol‐related liver disease

  2020cites this paper
• Особенности терапии алкогольной болезни печени у лиц молодого возраста

  2020cites this paper
• Алкогольная болезнь печени (АБП) у взрослых

  2020cites this paper
• Urinary ethyl glucuronide (uEtG) as a marker for alcohol consumption in liver transplant candidates: a real-world cohort

  2020influential citation
• Alcoholic liver disease

  2020cites this paper
• Role of Alcohol and Drug Detection by Regular Urine Sample Testing in pre-transplant evaluation for Alcohol Liver Disease Papel de la detección regular de sustancias en orina en pacientes en valoración pre-transplante hepático por hepatopatía alcohólica

  2020cites this paper
• Alcohol, its absorption, distribution, metabolism, and excretion in the body and pharmacokinetic calculations

  2019cites this paper
• Management of end-stage alcohol-related liver disease and severe acute alcohol-related hepatitis: position paper of the Italian Society on Alcohol (SIA).

  2019cites this paper
• Overcoming Alcohol Addiction in Patients with Alcohol-Related Liver Disease

  2019cites this paper
• Alcoholic liver disease: a modern look at diagnosis and treatment

  2019cites this paper
• The Clinical Presentations

  2018cites this paper
• Evaluation of laboratory tests for cirrhosis and for alcohol use, in the context of alcoholic cirrhosis.

  2018cites this paper
• Applications and Challenges for the Use of Phosphatidylethanol Testing in Liver Disease Patients (Mini Review)

  2018cites this paper
• A return to harmful alcohol consumption impacts on portal hemodynamic changes following alcoholic hepatitis

  2018cites this paper